Safety and efficacy of velpatasvir and sofosbuvir with or without ribavirin for the treatment of HCV genotypes 1-6: Results of the HCV-TARGET Study

Authors
Category Primary study
JournalJournal of Hepatology
Year 2017
This article has no abstract
Epistemonikos ID: e5a42ed5b98b0d447f23b9640935dee71df4c9ed
First added on: Feb 09, 2025